Paediatric Cushing's disease : Epidemiology, pathogenesis, clinical management and outcome
© 2021. The Author(s)..
Cushing's disease (CD) is rare in paediatric practice but requires prompt investigation, diagnosis and therapy to prevent long-term complications. Key presenting features are a change in facial appearance, weight gain, growth failure, virilization, disturbed puberty and psychological disturbance. Close consultation with an adult endocrinology department is recommended regarding diagnosis and therapy. The incidence of CD, a form of ACTH-dependent Cushing's syndrome (CS), is equal to approximately 5% of that seen in adults. The majority of ACTH-secreting adenomas are monoclonal and sporadic, although recent studies of pituitary tumours have shown links to several deubiquitination gene defects. Diagnosis requires confirmation of hypercortisolism followed by demonstration of ACTH-dependence. Identification of the corticotroph adenoma by pituitary MRI and/or bilateral inferior petrosal sampling for ACTH may contribute to localisation before pituitary surgery. Transsphenoidal surgery (TSS) with selective microadenomectomy is first-line therapy, followed by external pituitary irradiation if surgery is not curative. Medical therapy to suppress adrenal steroid synthesis is effective in the short-term and bilateral adrenalectomy should be considered in cases unfit for TSS or radiotherapy or when urgent remission is needed after unsuccessful surgery. TSS induces remission of hypercortisolism and improvement of symptoms in 70-100% of cases, particularly when performed by a surgeon with experience in children. Post-TSS complications include pituitary hormone deficiencies, sub-optimal catch-up growth, and persisting excess of BMI. Recurrence of hypercortisolism following remission is recognised but infrequent, being less common than in adult CD patients. With experienced specialist medical and surgical care, the overall prognosis is good. Early referral to an experienced endocrine centre is advised.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Reviews in endocrine & metabolic disorders - 22(2021), 4 vom: 30. Dez., Seite 817-835 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ferrigno, Rosario [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cortisol |
|---|
| Anmerkungen: |
Date Completed 14.03.2022 Date Revised 14.03.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11154-021-09626-4 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320767922 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320767922 | ||
| 003 | DE-627 | ||
| 005 | 20231225174313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11154-021-09626-4 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1069.xml |
| 035 | |a (DE-627)NLM320767922 | ||
| 035 | |a (NLM)33515368 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ferrigno, Rosario |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Paediatric Cushing's disease |b Epidemiology, pathogenesis, clinical management and outcome |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2022 | ||
| 500 | |a Date Revised 14.03.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a Cushing's disease (CD) is rare in paediatric practice but requires prompt investigation, diagnosis and therapy to prevent long-term complications. Key presenting features are a change in facial appearance, weight gain, growth failure, virilization, disturbed puberty and psychological disturbance. Close consultation with an adult endocrinology department is recommended regarding diagnosis and therapy. The incidence of CD, a form of ACTH-dependent Cushing's syndrome (CS), is equal to approximately 5% of that seen in adults. The majority of ACTH-secreting adenomas are monoclonal and sporadic, although recent studies of pituitary tumours have shown links to several deubiquitination gene defects. Diagnosis requires confirmation of hypercortisolism followed by demonstration of ACTH-dependence. Identification of the corticotroph adenoma by pituitary MRI and/or bilateral inferior petrosal sampling for ACTH may contribute to localisation before pituitary surgery. Transsphenoidal surgery (TSS) with selective microadenomectomy is first-line therapy, followed by external pituitary irradiation if surgery is not curative. Medical therapy to suppress adrenal steroid synthesis is effective in the short-term and bilateral adrenalectomy should be considered in cases unfit for TSS or radiotherapy or when urgent remission is needed after unsuccessful surgery. TSS induces remission of hypercortisolism and improvement of symptoms in 70-100% of cases, particularly when performed by a surgeon with experience in children. Post-TSS complications include pituitary hormone deficiencies, sub-optimal catch-up growth, and persisting excess of BMI. Recurrence of hypercortisolism following remission is recognised but infrequent, being less common than in adult CD patients. With experienced specialist medical and surgical care, the overall prognosis is good. Early referral to an experienced endocrine centre is advised | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Cortisol | |
| 650 | 4 | |a Cushing’s | |
| 650 | 4 | |a Hypercortisolism | |
| 650 | 4 | |a Paediatric | |
| 650 | 4 | |a Pituitary | |
| 700 | 1 | |a Hasenmajer, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Caiulo, Silvana |e verfasserin |4 aut | |
| 700 | 1 | |a Minnetti, Marianna |e verfasserin |4 aut | |
| 700 | 1 | |a Mazzotta, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Storr, Helen L |e verfasserin |4 aut | |
| 700 | 1 | |a Isidori, Andrea M |e verfasserin |4 aut | |
| 700 | 1 | |a Grossman, Ashley B |e verfasserin |4 aut | |
| 700 | 1 | |a De Martino, Maria Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Savage, Martin O |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Reviews in endocrine & metabolic disorders |d 2000 |g 22(2021), 4 vom: 30. Dez., Seite 817-835 |w (DE-627)NLM115974520 |x 1573-2606 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:4 |g day:30 |g month:12 |g pages:817-835 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11154-021-09626-4 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 4 |b 30 |c 12 |h 817-835 | ||